BR9713291A - Derivados de n-(imidazolilbutila) benzeno-sulfonamida que tem uma atividade antitrobótica - Google Patents

Derivados de n-(imidazolilbutila) benzeno-sulfonamida que tem uma atividade antitrobótica

Info

Publication number
BR9713291A
BR9713291A BR9713291-8A BR9713291A BR9713291A BR 9713291 A BR9713291 A BR 9713291A BR 9713291 A BR9713291 A BR 9713291A BR 9713291 A BR9713291 A BR 9713291A
Authority
BR
Brazil
Prior art keywords
alkyl
derivatives
antitrobotic
imidazolylbutyl
activity
Prior art date
Application number
BR9713291-8A
Other languages
English (en)
Inventor
Jean-Michel Altenburger
Gilbert Lassalle
Valerie Martin
Daniel Galtier
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of BR9713291A publication Critical patent/BR9713291A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68—Halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Abstract

Patente de Invenção: <B>''DERIVADOS DE N-(IMIDAZOLILBUTILA)BENZENO-SULFONAMIDA, SEU PREPARO E SUA APLICAçãO EM TERAPêUTICA''<D>. Compostos de fórmula (I), na qual R~ 1~ e R'~ 1~ representam hidrogênio, halogênio ou (C~ 1~-C~ 4~)alquila, R~ 2~ representa um grupo piperidin-1-ila, 1,2,3,6-tetra-hidropiridin-1-ila eventualmente substituídos, hexa-hidro-1H-azepin-1-ila, hepta-hidroazocin-1-ila, octa-hidro-1H-azonin-1-ila, (a) (A-B) = -CONR", m = 1 a 2 e p = 1 a 2), (b) (Q = carbono ou nitrogênio, D = (C~ 1~-C~ 4~)alquila ou -CH~ 2~CF~ 3~ e r = 1 a 3); R~ 3~ representa (C~ 1~-C~ 5~)alquila, -COR~ 5~ [R~ 5~ sendo (C~ 1~-C~ 4~)alquila, -(CH~ 2~)~ n~OCH~ 3~, -CH~ 2~O(C~ 2~H~ 4~O)~ n~CH~ 3~, -(CH~ 2~)~ n~CF~ 3~, -(CH~ 2~)~ n~OH (n igual a 1 a 4)], -SO~ 2~R~ 6~, -CONHR~ 6~, -SO~ 2~N(R~ 6~)~ 2~ (R~ 6~ sendo (C~ 1~-C~ 4~)alquila), R~ 4~ representa hidrogênio ou halogênio e A representa fenila ou heterociclo, eventualmente substituídos, ou ciclo(C~ 5~-C~ 8~)alquila. Aplicação em terapêutica.
BR9713291-8A 1996-11-22 1997-11-19 Derivados de n-(imidazolilbutila) benzeno-sulfonamida que tem uma atividade antitrobótica BR9713291A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9614309A FR2756285B1 (fr) 1996-11-22 1996-11-22 Derives de n-(imidazolylbutyle)benzenesulfonamide, leur preparation et leur application en therapeutique
PCT/FR1997/002079 WO1998022443A1 (fr) 1996-11-22 1997-11-19 Derives de n-(imidazolylbutyle) benzenesulfonamide ayant une activite antithrombotique

Publications (1)

Publication Number Publication Date
BR9713291A true BR9713291A (pt) 1999-10-26

Family

ID=9497920

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9713291-8A BR9713291A (pt) 1996-11-22 1997-11-19 Derivados de n-(imidazolilbutila) benzeno-sulfonamida que tem uma atividade antitrobótica

Country Status (20)

Country Link
EP (1) EP0946517A1 (pt)
JP (1) JP2001504128A (pt)
KR (1) KR20000069063A (pt)
CN (1) CN1238765A (pt)
AR (1) AR009627A1 (pt)
AU (1) AU5226498A (pt)
BG (1) BG103414A (pt)
BR (1) BR9713291A (pt)
CA (1) CA2270478A1 (pt)
CO (1) CO4910158A1 (pt)
CZ (1) CZ178299A3 (pt)
EE (1) EE9900201A (pt)
FR (1) FR2756285B1 (pt)
HU (1) HUP9904599A2 (pt)
IL (1) IL129546A0 (pt)
NO (1) NO992436L (pt)
SK (1) SK66799A3 (pt)
TR (1) TR199901143T2 (pt)
WO (1) WO1998022443A1 (pt)
ZA (1) ZA9710515B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2783521B1 (fr) * 1998-09-18 2002-04-26 Synthelabo Derives de n-(arginyl) benzenesulfonamide, leur preparation et leur application en therapeutique
FR2806722B1 (fr) * 2000-03-23 2002-05-17 Sanofi Synthelabo Derives de n-(heterocyclylbutyl) benzene-ou pyridine sulfonamide, leur preparation et leur application en therapeutique
EP3201168B1 (en) 2014-09-29 2020-03-18 Cellix Bio Private Limited Compounds and compositions for the treatment of multiple sclerosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2689130B1 (fr) * 1992-03-30 1994-05-27 Synthelabo Derives de 1-[2 (arylsulfonylamino)ethyl-1-oxo] piperidine, leur preparation et leur application en therapeutique.
FR2710066B1 (fr) * 1993-09-14 1995-10-20 Synthelabo Dérivés de 1-[2-amino-5-[1-(triphénylméthyl-1H-imidazol-4-yl]-1-oxopentyl]piperidine, leur préparation et leur utilisation comme intermédiaires de synthèse.
FR2727410B1 (fr) * 1994-11-25 1996-12-20 Synthelabo Chlorures de sulfonyles, leur preparation et leur utilisation comme intermediaires de synthese
FR2728570B1 (fr) * 1994-12-23 1997-04-11 Synthelabo Derives de 1-oxo-2-(phenylsulfonylamino)pentylpiperidine, leur preparation et leur application en therapeutique
DE19548797A1 (de) * 1995-12-27 1997-07-03 Thomae Gmbh Dr K Substituierte 2-Amino-imidazole, ihre Herstellung und ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
KR20000069063A (ko) 2000-11-25
NO992436D0 (no) 1999-05-20
CA2270478A1 (en) 1998-05-28
EP0946517A1 (fr) 1999-10-06
SK66799A3 (en) 2000-02-14
CO4910158A1 (es) 2000-04-24
ZA9710515B (en) 1998-06-10
AR009627A1 (es) 2000-04-26
CZ178299A3 (cs) 1999-08-11
EE9900201A (et) 1999-12-15
NO992436L (no) 1999-07-22
WO1998022443A1 (fr) 1998-05-28
BG103414A (en) 2000-01-31
TR199901143T2 (xx) 1999-08-23
CN1238765A (zh) 1999-12-15
FR2756285B1 (fr) 1998-12-18
IL129546A0 (en) 2000-02-29
HUP9904599A2 (hu) 2000-06-28
JP2001504128A (ja) 2001-03-27
AU5226498A (en) 1998-06-10
FR2756285A1 (fr) 1998-05-29

Similar Documents

Publication Publication Date Title
BR9813848A (pt) Composto heterocìclico fundido substituìdo, uso do mesmo, e, composição farmacêutica.
BRPI9602933B8 (pt) Compostos dihidrodibenzo [b,f] azepinas substituídas.
BR9807132A (pt) Derivados de pirrolidina tendo atividade inibitória de fosfolipase a2
BR9714787A (pt) Compostos de 4- fenilpiperidina e processo para sua preparação
BR9912029A (pt) Compostos reacionais de amina compreendendo um ou mais ingredientes ativos
WO2001056989A3 (en) Inhibitors of factor xa
DE69919397D1 (de) Thrombin-inhibitoren
DK188288D0 (da) 1-phenyl-3-naphthalenyloxypropanaminer, fremgangsmaade til fremstilling af saadanne forbindelser og farmaceutiske midler indeholdende disse
BR9910573A (pt) Compostos antipicornavirais, preparação e uso dos mesmos
BR9912612A (pt) Composto de maleimida dissubstituìdo e seu usofarmacêutico
NZ333063A (en) Dibenzofuran sulfonamide derivatives as matrix metalloproteinase inhibitors
NO944930L (no) Hemming av dysfunksjonell uterin blödning
HUP0401235A2 (hu) 5-HT6 receptor affinitással rendelkező arilszulfonil-származékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyászati készítmények
ES2171964T3 (es) Esteres dibenzodihidropiridinecarboxilicos y su uso en metodos de ensayo quimiluminiscente.
BR0100234A (pt) Compostos de piperidina-4-sulfonamida, processo para a sua preparação e composições farmacêuticas contendo os mesmos
EE200000298A (et) Bifenüülamidiini derivaadid, eelravim, vere koagulatsiooniinhibiitor ning profülaktiline ja terapeutiline toimeaine tromboosi või emboolia vastu
ES2115650T3 (es) Derivados de tiazolidina que contienen un grupo quinona, su preparacion y utilizacion en terapeutica.
NO972887L (no) Piperidineddiksyrederivater anvendelige som fibrinogen-antagonistmiddel
ES2189285T3 (es) Nuevas piranonas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen
HUP0102025A2 (hu) Diaril-1,3,4-oxadiazolon-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
BR9713291A (pt) Derivados de n-(imidazolilbutila) benzeno-sulfonamida que tem uma atividade antitrobótica
BR0015333A (pt) Derivados de isoxazol como inibidores de fosfodiesterase vii
BR9907497A (pt) Compostos de imidazolina, um processo para seu preparo e compostos farmacêuticos contendo os mesmos
BR9909647A (pt) Compostos de piridino arilpiperazinas substituìdos, de utilidade no tratamento de hiperplasia prostática benigna
BR0107282A (pt) Composto, composição farmacêutica e métodos para prevenir ou tratar uma condição em um mamìfero e para inibir a coagulação de amostras biológicas

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]